Results 171 to 180 of about 12,518 (225)

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen. [PDF]

Front Immunol
Guo P, Li W, Chen S, Yang X, Ma L, Wu C, Li G, Wang W.   +7 more
europepmc   +1 more source

Obinutuzumab as a Rescue Therapy in Anti-Rituximab Antibody-Positive Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Liu Y, Wu D, Xue R, Chen Y, Wan Q.
europepmc   +1 more source

PLA2R-positive primary membranous nephropathy in an adolescent with type 1 diabetes mellitus and autoimmune hypothyroidism: a case report. [PDF]

CEN Case Rep
Madhuri PS, Venkatachari M.
europepmc   +1 more source

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Trillini M, Portalupi V, Gennarini A, Surdi L, Currado A, Marasà M, Podestà MA, Villa A, Peracchi T, Fidone D, Rubis N, Diadei O, Guarinoni C, Casiraghi F, Todeschini M, Cugini D, Carrara F, Martinetti D, Rizzo P, Remuzzi G, Ruggenenti P.   +20 more
europepmc   +1 more source

Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study. [PDF]

BMC Nephrol
Huang Y, Meng X, Wu S, Miao X, Qin L, Zhang K, Sun J, Wang J.   +7 more
europepmc   +1 more source

Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India. [PDF]

World J Nephrol
Wani MA, Khan I, Rather JI, Bhat MA, Wani MM, Wani IA, Sheikh RY, Parry MA.   +7 more
europepmc   +1 more source

Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab? [PDF]

Drug Des Devel Ther
Cao H, Feng Y, Li X, Ke B, Gong L.
europepmc   +1 more source

Combination of B-cell-guided rituximab and low-dose tacrolimus for primary membranous nephropathy: a retrospective cohort study. [PDF]

Front Med (Lausanne)
Wang L, Huo S, You Z, Dong Y, Gan Y, Zhang Z, Gu Y, Yan L, Shao F.   +8 more
europepmc   +1 more source

Extracellular Vesicle-Based Urinary Proteomic Signatures Predict Remission and Relapse in Primary Membranous Nephropathy. [PDF]

Kidney Dis (Basel)
Zeng L, Sun Y, Liang T, Tang H, Ye Z, Han T, Hu Z, Peng H.   +7 more
europepmc   +1 more source